Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management

Small bowel adenocarcinoma (SBA) is a rare malignancy, with a rising incidence in recent decades, and accounts for roughly 40% of all cancers of the small bowel. The majority of SBAs arise in the duodenum and are associated with a dismal prognosis. Surgery remains the mainstay of treatment for local...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelsomino, Fabio, Balsano, Rita, De Lorenzo, Stefania, Garajová, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870676/
https://www.ncbi.nlm.nih.gov/pubmed/35200603
http://dx.doi.org/10.3390/curroncol29020104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870676/
https://www.ncbi.nlm.nih.gov/pubmed/35200603
http://dx.doi.org/10.3390/curroncol29020104

Ejemplares similares